2024 Annual Conference Brochure - Flipbook - Page 16
SATURDAY, SEPTEMBER 28, 2024
BREAKOUT SESSIONS
TRACK 2: DEVICE
TRACK 2: DECENTRALIZED CLINICAL TRIALS
Sat., Sept 28 8:30 to 9:15
Track: Device Research
Medical Device Clinical Research Risk Determination
Ms. Headlee will consider the risk classifications for
medical device clinical research (Exempt, NSR and SR).
She will also facilitate a discussion of helpful tips and
best practices for navigating the IDE pathway. 217
Presenter: Donna Headlee, BSN, RN, CCRP, Recently Retired
Branch Chief, FDA, CDRH, OCE, DICE, PPB
Sat., Sept 28 1:40 to 2:25
Track: DCT
Direct to Participant Research
Ms. Dalal will discuss the experience and process for
collecting direct data from participants (no sites
involved). 225
Presenter: Prachi Dalal, BPharm, MS, MBA, CCRP, Senior
Clinical Program Manager, Recordati Rare Diseases US
Sat., Sept 28 9:20 to 10:05
Track: Device Research
Artificial Intelligence/Machine Learning in Medical
Device Studies
More and more investigational devices now have AI/ML
algorithms embedded in them. In this session, Ms.
Norman will discuss the basic of AI/ML in medical devices
and how FDA is requiring clinical studies to be designed,
as well as the operational challenges that are presented
to sponsors and clinical sites due to these study designs.
219
Presenter: Dawn Norman, MS, Partner, MRC Global
Sat., Sept 28 10:50 to 11:35
Track: Device Research
Points to Consider for Medical Devices and
ClinicalTrials.gov
Attendees will consider the rationale behind the
requirements of study registration, discuss the unique
requirements and considerations for medical devices and
ClinicalTrials.gov registration. Ms. Ferrazzano Yaussy will
also review the agencies requiring registration and
requirements for clinical trials involving medical devices.
221
Presenter: Cristina Ferrazzano Yaussy, MPH, CCRP, Research
Regulatory Affairs Specialist, Dartmouth-Hitchcock Medical
Center
Sat., Sept 28 11:40 to 12:25
Track: Device Research
Looking through the Medical Device Sponsor’s Lens:
Practical tools for assessing Lessons Learned and
How to Operationalize for Future Studies
What happens when the research study is finally closed,
and the study result is published or maybe not? Many
times, Project Managers come out of this process with
lots of bruises and blacklisted sites or shoutouts and
stellar sites. While this is good to know, this knowledge
alone is not enough. Ms. Annan will discuss how to use
effective tools to assess sites and investigator
performances after study closure and how to
operationalize the lessons learned for future studies
based on a 5-year global medical device studies for
about 500 subjects across 50 sites. 223
Presenter: Gladys Annan, MBA, BA, CCRP, PMP, Senior
Manager, Clinical Research, STERIS Endoscopy
15
7
Sat., Sept 28 2:30 to 3:15
Track: DCT
The ABCs and GCP of Successfully Implementing
Decentralized Trials
In May 2023, the FDA issued draft guidance for
decentralized clinical trials. Initially embraced as a
means to adapt to lockdown conditions during the
pandemic, the benefits of remote clinical trial models,
including greater operational flexibility, access to diverse
populations of study participants, and cost savings are
now widely accepted. However, as sites have more
opportunities to participate in decentralized trials it is
important to be cognizant of the potential GCP risks and
measures sites can take to ensure participant rights,
safety, and data integrity. 227
Presenter: Lisa Harewood, CCRP, Senior Clinical Trials
Regulatory Specialist, Hope Clinic of Emory Vaccine Center
Sat., Sept 28 3:45 to 4:30
Track: DCT
The New Frontier: Operationalizing Community Sites
to Improve Patient Access & Diversity
Ms. Surdam will discuss the utilization and
operationalization of community sites such as pharmacy
chains, lab networks, and independent or local health
clinics to overcome obstacles for the use of decentralized
community sites to improve patient access and meet
diversity requirements for clinical trials. 229
Presenter: Kristin Surdam, MS, PMP, CCRC, Senior Director,
KOL & Strategy, Florence Healthcare
Sat., Sept 28 4:35 to 5:20
Track: DCT
Clinical Research in Functional Medicine
Mr. Wehage will discuss the perspectives of a very rural
community that has been involved with clinical trials for
about eight years. 231
Presenter: Scott Wehage, MS, CCRP, Director, Clinical Trials